The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting

INTRODUCTION: The Oncotype DX test is a genomic assay that generates a Recurrence Score (RS) predicting the 10-year risk of recurrence and response to adjuvant chemotherapy in ER+/HER2− breast cancer patients. The aims were to determine breast cancer distant recurrence and correlate with adjuvant ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Joseph Do Woong, Hughes, T. Michael D., Marx, Gavin, Boyages, John, Rutovitz, Josie, Hasovits, Csilla, Parasyn, Andrew, Edirimanne, Senarath, Ngui, Nicholas K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187289/
https://www.ncbi.nlm.nih.gov/pubmed/35711899
http://dx.doi.org/10.1155/2022/1199245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187289/
https://www.ncbi.nlm.nih.gov/pubmed/35711899
http://dx.doi.org/10.1155/2022/1199245

Ejemplares similares